GRAMINEX®, L.L.C. Final Publication of a Peer Reviewed Clinical Trial with Graminex® Flower Pollen Extract Focusing on Women’s Urinary Incontinence in Current Urology.
Graminex®, L.L.C. is pleased to announce publication of a peer reviewed clinical study with Graminex® Flower Pollen Extract for women’s urinary incontinence and urinary health in Current Urology. The study was conducted as a randomized, double-blind, placebo-controlled study to investigate the effectiveness of Graminex® Flower Pollen Extracts in 114 healthy women with urinary incontinence. It was concluded that significant and meaningful reductions in UI severity were found in the Graminex® RCT Fem™ UI study group along with significant improvement in stress-induced urinary leakage volume with the PollenBerry® study group. A full version is available at: Current Urology - Original Article
“Many women experience urinary incontinence throughout their lives during postpartum, menopause, and the natural aging process. There is limited natural support to help improve the symptoms of urinary incontinence currently on the market. With this peer reviewed publication, Graminex is excited to offer a natural product to help improve women’s lives, when it’s needed most,” said Colleen May, CBO.
About Graminex ® , L.L.C.
Graminex®,L.L.C. is the leading producer of natural and non-solvent Graminex® Flower Pollen Extract™. Graminex® directly owns and manages more than 6,500 acres of farmland in Northwest Ohio to meet its customer’s needs. Graminex’s active ingredients are grown and processed for the dietary supplement, nutraceutical, pharmaceutical, food and skin care industries. Graminex® markets its own branded line of raw materials and dietary supplements, focusing on prostate care, urinary care, menopausal support, and skin care.
For further information please contact Graminex®,L.L.C., Colleen May at +1 (419) 278-1023 or by e-mail at graminex@graminex.com. You may also visit www.graminex.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240513362788/en/
Contact information
Colleen E. May
Chief Business Officer
bugs@graminex.com
+1 (419) 278-1023
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New Multi-Mission Beechcraft King Air Demonstrator Unveiled at Paris Air Show16.6.2025 09:30:00 EEST | Press release
Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company, announced its new multi-mission Beechcraft King Air demonstration aircraft will be making its show and European debut at the 2025 Paris Air Show. The aircraft is equipped to showcase a wide range of missions available on the versatile and reliable Beechcraft King Air platform, and will be on static display Monday, June 16, through Thursday, June 19, at the Textron Pavilion A2. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250615940392/en/ From Wichita, Kansas to Paris, France: Beechcraft King Air demonstrator makes international debut “The King Air’s acquisition and operation cost, combined with excellent speed, range and payload capacity make it an excellent value for a wide range of special missions,” said Bob Gibbs, vice president, Special Missions Sales. “The best-selling turboprop serves as an ideal platform for intelligence, surveillance and reconnaissance, ut
Ant International Announces Sustainability Framework, Serving 100 mn Merchants to Advance Inclusive Growth in Re-globalisation16.6.2025 08:00:00 EEST | Press release
Ant International, a leading global digital payment, digitisation and financial technology provider, today announced its Sustainability Framework in its first independent Sustainability Report. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250615891282/en/ Ant International announces Sustainability Framework in its Inaugural Sustainability Report A New Chapter of Growth with New Mission and Vision at a Critical Moment 2024 is a transformative year for Ant International, which became independent after a reorganisation of Ant Group. With headquarters in Singapore and over 30 offices around the world, Ant International provides cross-border digital payment, commerce and finance solutions to merchants and financial institutions, connecting 100 million+ merchants to global consumers across its 4 business units: global e-wallet gateway service (Alipay+), merchant payment service (Antom), cross-border business account service (Wor
Cosmetics Industry Icon Leonard A. Lauder, Chairman Emeritus, The Estée Lauder Companies, Passes Away15.6.2025 19:54:00 EEST | Press release
It is with deep sadness that The Estée Lauder Companies Inc. (NYSE: EL) announces that Chairman Emeritus Leonard A. Lauder passed away on June 14, at the age of 92, surrounded by family. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250615313230/en/ Leonard A. Lauder Mr. Lauder was born in 1933 in New York City, the oldest son of Estée and Joseph H. Lauder, the founders of The Estée Lauder Companies. He was a graduate of the Bronx High School of Science, the University of Pennsylvania’s Wharton School, and the Officer Candidate School of the United States Navy. Mr. Lauder studied at Columbia University’s Graduate School of Business. He served as a lieutenant in the U.S. Navy and as a Navy reservist, for which the U.S. Navy Supply Corps Foundation later recognized him with its Distinguished Alumni Award. He formally joined Estée Lauder in 1958, and for more than six decades, Mr. Lauder was a visionary and an innovator, helpi
Positive Late-Breaking Data for Incyte’s First-in-Class mutCALR-targeted therapy INCA033989 in Essential Thrombocythemia Presented at EHA202515.6.2025 10:15:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced the first clinical data from two studies evaluating the safety, tolerability and efficacy of INCA033989, a novel, first in class, Incyte-discovered, targeted monoclonal antibody in patients with mutant calreticulin (mutCALR)-expressing myeloproliferative neoplasms (MPNs). These data – featured today in the Late-Breaking Oral Session (#LB4002) at the European Hematology Association 2025 (EHA2025) Congress in Milan, Italy – focus on the dose escalation portion of thestudies in patients with high risk essential thrombocythemia (ET) who are resistant/intolerant to prior cytoreductive therapy. The studies evaluated the safety and efficacy of INCA033989 in patients with ET as measured by hematologic response and reduction in mutCALR variant allele frequency (VAF). Results as of April 4, 2025, showed rapid and durable normalization of platelet counts across all dose levels, with a trend toward improved responses in higher doses (>400 mg), in patients with
Perma-Pipe International Holdings, Inc. Announces First Quarter Fiscal 2025 Financial Results13.6.2025 16:14:00 EEST | Press release
Perma-Pipe International Holdings, Inc. (NASDAQ: PPIH) announced today financial results for the first quarter ended April 30, 2025. “Sales for the first quarter were $46.7 million, resulting in an increase of $12.4 million, or 36.2%, compared to $34.3 million in the same quarter last year. Net income attributable to common stock of $5.0 million was an increase of $3.6 million, or 243%, compared to $1.4 million in the first quarter of the prior year,” noted President and CEO Saleh Sagr. Backlog currently stands at $131.1 million, a decrease of $7.0 million, compared to $138.1 million at January 31, 2025. However, the Company has experienced a significant increase in backlog of $68.0 million, or 108%, compared to $63.1 million at April 30, 2024. We feel encouraged with the level of backlog we have obtained, which remains more than double the level of reported backlog at the end of the first quarter last year,” Mr. Sagr continued. “Our first quarter results represent unprecedented perfor
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom